We report the case of a 54-year-old woman with aplastic anemia, who developed transient pulmonary infiltrates following intravenous infusion of rabbit antithymocyte globulin (ATG) for 3 days. There was no other explanation than the infusion of ATG for the infiltrates. Rechallenge with ATG induced the recurrence of opacities on the chest radiograph. Although rarely involved with only 4 previous reports, ATG should be included in the list of drugs capable of inducing pulmonary infiltrates.

Richardson AJ, Higgins RM, Liddington M, Murie J, Ting A, Morris PJ: Antithymocyte globulin for steroid resistant rejection in renal transplant recipients immunosuppressed with triple therapy. Transpl Int 1989;2:27–32.
Dean NC, Amend WC, Matthay MA: Adult respiratory distress syndrome related to antilymphocyte globulin therapy. Chest 1987;91:619–620.
Murdock DK, Lawless CE, Collins E, Huml JP, Pifarre R: ARDS following equine ATG therapy. Chest 1987;92:578.
Walton GD, Gualtieri RJ: Antithymocyte globulin-induced adult respiratory distress syndrome. Arch Intern Med 1998;158:1380.
Zomas A, Marsh JCW, Harrison NK, Hyer SL, Nussey SS, Knee G, Wilson AG, Lakhani A, Gordon-Smith EC: Rapid progression of fibrosing alveolitis and thyrotoxicosis after antithymocyte globulin therapy for aplastic anemia. Ann Hematol 1995;71:49–51.
Camus P, Gibson GJ: Adverse pulmonary effects of drugs and radiation; in Brewis RM, Corrin B, Geddes DM, Gibson GJ (eds): Respiratory Medicine. London, Saunders, 1995, vol 1, pp 630–657.
Foucher P, Biour M, Blayac JP, Godard P, Sgro C, Kuhn M, Vergnon JM, Vervloet D, Pfitzenmeyer P, Ollagnier M, Mayaud C, Camus P: Drugs that may injure the respiratory system. Eur Respir J 1997;10:265–279.
Powell-Jackson PR, Carmichael FJL, Calne RY, Williams R: Adult respiratory distress syndrome and convulsions associated with administration of cyclosporine in liver transplant recipients. Transplantation 1984;38:341–343.
Carbone L, Appel GB, Benvenisty AI, Cohen DJ, Kunis CL, Hardy MA: Adult respiratory distress syndrome associated with oral cyclosporine. Transplantation 1987;43:767–768.
Blaauw AAM, Leunissen KML, Cheriex EC, Wolters J, Kootstra G, van Hooff JP: Disappearance of pulmonary leak syndrome when intravenous cyclosporine is replaced by oral cyclosporine. Transplantation 1987;43:758–759.
Stubblefield PG: Pulmonary edema occurring after therapy with dexamethasone and terbutaline for premature labor. Am J Obstet Gynecol 1978;132:341–342.
Pisani RJ, Rosenow ECI: Pulmonary edema associated with tocolytic therapy. Ann Intern Med 1989;110:714–718.
Krimerman S, Potasman I, Barak A: Pulmonary reactions associated with the combined use of amphotericin B and leukocyte transfusion. Crit Care Med 1989;17:1081.
Arning M, Heer-Sonderhoff AH, Wehmeir A, Schneider W: Pulmonary toxicity during infusion of liposomal amphotericin B in two patients with acute leukemia. Eur Clin Microbiol Infect Dis 1995;14:41–43.
Katoh M, Shikoshi K, Takada M, Umeda M, Tsukahara T, Kitagawa S, Shirai T: Development of interstitial pneumonitis during treatment with granulocyte colony-stimulating factor. Ann Hematol 1993;67:201–202.
Seebach J, Speich R, Fehr J, Tuchschmid P, Russi E: GM-CSF-induced acute eosinophilic pneumonia. Br J Haematol 1995;90:963–965.
Yokose N, Ogata K, Tamura H, An E, Nakamura K, Kamikubo K, Kudoh S, Dan K, Nomura T: Pulmonary toxicity after granulocyte colony stimulating factor-combined chemotherapy for non-Hodgkin’s lymphoma. Br J Cancer 1998;77:2286–2290.
van Woensel JBM, Knoester H, Leeuw JA, van Aalderen WMC: Acute respiratory insufficiency during doxorubicin, cyclophosphamide, and G-CSF therapy. Lancet 1994;344:759–760.
Bastion Y, Reyes F, Bosly A, Gisselbrecht C, Yver A, Gilles E, Maral J, Coiffier B: Possible toxicity with the association of G-CSF and bleomycin. Lancet 1994;343:1221–1222.
Saxman SB, Nichols CR, Einhorn LH: Pulmonary toxicity in patients with advanced-stage germ cell tumors receiving bleomycin with and without granulocyte colony stimulating factor. Chest 1997;111:657–660.
Jeter EK, Spivey MA: Noninfectious complications of blood transfusion. Hematol Oncol Clin North Am 1995;9:187–204.
Lindgren L, Ylihankala A, Halme L, Koskimies S, Orko R: Transfusion-related acute lung injury (TRALI) after fresh frozen plasma in a patient with coagulopathy. Acta Anaesthesiol Scand 1996;40:641–644.
Ramanathan RK, Triulzi DJ, Logan TF: Transfusion-related acute lung injury following random donor platelet transfusion: A report of two cases. Vox Sang 1997;73:43–45.
Virchis AE, Patel RK, Contreras M, Navarrete C, Kaczmarksi RS, Jan-Mohamed R: Lesson of the week: Acute non-cardiogenic lung oedema after platelet transfusion. Br Med J 1997;314:880–882.
Popovsky MA, Moore SB: Diagnostic and pathogenetic considerations in transfusion-related acute lung injury. Transfusion 1985;25:573–577.
Heffner JE, Sahn SA: Salicylate-induced pulmonary edema: Clinical features and prognosis. Ann Intern Med 1981;95:405–409.
Biron P, Dessureault J, Napke E: Acute allergic interstitial pneumonitis induced by hydrochlorothiazide. Can Med Assoc J 1991;145:28–34.
Frankenfeld RH: Pulmonary edema caused by nitrofurantoin. Ann Intern Med 1967;66:1055.
Scott J, Oakley CM, McCarthy A, Walport MJ, Hughes JMB, Silverman M: Grand Rounds – Hammersmith Hospital. β-Adrenergic agonists and pulmonary oedema in preterm labour. Must be used with care. Br Med J 1994;308:260–262.
Smith-Whitley K, Lange B: Fatal all-trans retinoic acid pneumonitis. Ann Intern Med 1993;118:472–473.
Ochsner SF, Hatch HB, Leonard GL: Hypersensitivity and the lung. Am J Roentgenol 1969;107:290–299.
Rault R, Piraino B, Johnston GR, Oral A: Pulmonary and renal toxicity of intravenous immunoglobulin. Clin Nephrol 1991;36:83–86.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.